|Year : 2015 | Volume
| Issue : 3 | Page : 341-348
Bispectral index-guided induction of anesthesia by ketofol infusion provides the same cardiovascular stability like that of etomidate infusion
Hesham F Soliman
Department of Anesthesia, Faculty of Medicine, Ain-Shams University, Cairo, Egypt
|Date of Submission||09-Nov-2014|
|Date of Acceptance||14-Apr-2015|
|Date of Web Publication||29-Jul-2015|
Hesham F Soliman
Alnoor Specialist Hospital, PO Box 6251, Makkah 21955, Kingdom of Saudi Arabia
Source of Support: None, Conflict of Interest: None
Various techniques have been tried to maintain cardiovascular stability with anesthesia induction. This study compares the cardiovascular effects of propofol-ketamine mixture versus etomidate during the induction of anesthesia.
Materials and methods
A total of 50 patients undergoing elective surgeries were randomly assigned according to the induction agents into two groups: group K (n = 25) received propofol-ketamine mixture (ketofol), and group E (n = 25) received etomidate, both by bispectral index (BIS) guidance. Mean arterial pressure (MAP), cardiac output (CO), heart rate, and systemic vascular resistance (SVR) were measured 6 min preintubation and up to 16 min postintubation. P-value less than 0.05 was considered statistically significant.
MAP and SVR were significantly increased (P < 0.001) in both groups immediately and up to 4 min postintubation compared with baseline, whereas CO and stroke volume (SV) remain unchanged. Meanwhile, there was no significant difference between both groups with regard to CO, MAP, SVR, heart rate, and BIS at each time intervals.
BIS-guided/induction by propofol-ketamine mixture is effective as etomidate in maintaining cardiac stability; however, both techniques did not prevent any hemodynamic changes as hypotension and hypertension preintubation and postintubation, respectively.
Keywords: bispectral index, etomidate, hemodynamics, intubation, ketofol, propofol, induction of anesthesia
|How to cite this article:|
Soliman HF. Bispectral index-guided induction of anesthesia by ketofol infusion provides the same cardiovascular stability like that of etomidate infusion
. Ain-Shams J Anaesthesiol 2015;8:341-8
|How to cite this URL:|
Soliman HF. Bispectral index-guided induction of anesthesia by ketofol infusion provides the same cardiovascular stability like that of etomidate infusion
. Ain-Shams J Anaesthesiol [serial online] 2015 [cited 2021 May 9];8:341-8. Available from: http://www.asja.eg.net/text.asp?2015/8/3/341/159004
| Introduction|| |
Hemodynamic changes usually occur during the induction of anesthesia by either intravenous induction agents or endotracheal intubation. Several studies had been conducted to compare the hemodynamic effects of propofol and etomidate, but it lacks monitoring the anesthetic depth, which has a relation with hemodynamic measurements of the cardiac parameters in those trials that might give explanation for these circulatory changes ,,,,,,, .
Induction of anesthesia with propofol is associated with significant blood pressure reduction and hemodynamic instability, especially in geriatric patients  . Patients with hypotension and those with American Society of Anesthesiologists' physical status (ASA)>II are more vulnerable to marked drop in blood pressure with propofol induction  . In addition to its amnesic and analgesic properties, ketamine increases heart rate (HR) and blood pressure by activating the sympathetic nervous system  . It was observed that a combination of ketamine and propofol reduced consumption of propofol and opioids and ensured better hemodynamic and respiratory stability ,, .
Etomidate produces less cardiovascular depression than other commonly used induction agents such as thiopentone Na and propofol. They are considered the induction agents of choice for high-risk patients with cardiorespiratory diseases, and for that reason they have also been used for laryngeal mask insertion  . The aim of this study is the assessment of the cardiovascular effects such as mean arterial pressure (MAP), HR, systemic vascular resistance (SVR), SV, and cardiac output (CO) of ketofol and etomidate infusions during the induction of anesthesia and tracheal intubation. It was suggested that bispectral index (BIS)-guided titration of both anesthetics might reduce the required dose and alleviate the negative cardiovascular effects.
| Materials and methods|| |
This prospective randomized double-blinded trial was conducted in Al-Noor Specialist Hospital, Makkah, Saudi Arabia, from February 2013 to March 2014.
After approval from the Research and Ethics Committee, 55 patients were screened for eligibility to participate in the study. Written informed consent was obtained from 50 patients with age of 18-60 years, both sex, American Society of Anesthesiologists' physical class I or II patients, and scheduled for elective surgery.
Patients with BMI above 30, allergic to study medications, anticipated difficult airway, intubation failed once or intubation time exceeded 20 s, psychiatric illness, language barrier and patients on β-blockers, α-blockers, or sympathomimetics were excluded from the study. No premedications were offered. In the operating theater, standard monitoring was applied in the form of noninvasive blood pressure, ECG, and pulse oximetry (Drager, Primus, Dräger Medical GmbH, Lübeck, Germany). Patients' foreheads were prepared with alcohol swap followed by BIS electrode application (Covidien, Lake Forest, IL, Massachusetts, USA). For noninvasive cardiovascular parameter measurements, a cuff sensor applied to the patients' index and middle fingers that was connected to a monitor, which displayed beat to beat MAP, HR, SVR, SV, and CO (CNAP monitor 500 HD; CNsystems Medizintechnik AG, Graz, Austria) [Figure 1]. Baseline measurements were recorded and, 1 min after, fentanyl (fentanyl; Janssen-Cilag Pharma, Turnhoutseweg 30, B-2340 Beerse, Belgium) 2 μg/kg was administered intravenously. Two minutes later, the induction of anesthesia was started. The patients were randomized by a computer-generated random list enclosed in opaque envelopes to one of two groups. The ketofol group (group K; n = 25) received a drug mixture of 20 ml of ketamine 10 mg/ml (Ketam 10; Hekma Pharmaceutical, Amman, Jordan) with 20 ml propofol 1% (Fresenius Kabi, Bad Homburg, Germany) to constitute 40 ml mixture of 5 mg/ml for each drug, which was infused during induction at a rate of 0.5 mg/kg/min, whereas the etomidate group (group E; n = 25) received etomidate (hypomidate; Janssen, Beerse, Belgium) prepared as 2 mg/ml concentration in 40 ml volume, which was infused during induction at a rate of 0.05 mg/kg/min. The study medications were prepared by independent contributor in 50 ml syringes (the perfusor, Alaris CC for 50 ml syringe; Cardinal Health, Dublin, Ireland) covered by aluminum paper and loaded in syringe pump (Fresenius vial, Module DPS + IS3; La Grande Chamin, Brezins, France).
After loss of eyelash reflex and BIS values reach 60, the anesthetic drug infusion was stopped, and rocuronium 0.6 mg/kg (Esmeron; NV Organon, Oss, the Netherlands) was administered intravenously, followed by manual ventilation of the patients' lungs for 1 min, and patients' tracheas were intubated by the examiner, who was blinded to the study medications. The independent contributor recorded a total consumed dose of each anesthetic agent, the time for eye lash reflex loss, time to BIS 60 and intubation time that was measured from the passage of the laryngoscope blade patients' incisors to appearance of the displayed end-tidal CO 2 . After intubation, the patients' lungs were mechanically ventilated with sevoflurane 1 vol% in oxygen and air mixture (1: 1), 3 l/min fresh gas flow and minute ventilation was adjusted to maintain normocapnia. Cardiovascular and BIS values were recorded at −6 min (baseline), −4 min, −1 min, 0 min (intubation), 1 min, 4 min, 7 min, 10 min, 13 min, and 16 min postintubation. End-tidal CO 2 (EtCO 2 ) and end-tidal sevoflurane (ET Sevo) were recorded at 1 and 5 min after intubation. Complications were planned to be recorded and treated as follows: hypotension (MAP ≤55 mmHg) treated with phenylephrine 1 μg/kg incremental doses until the desired clinical effect was achieved. Hypertension (MAP ≥100 mmHg) and tachycardia (HR ≥90/min) were treated with fentanyl 1 μg/kg. Bradycardia (HR ≤40/min) was treated with atropine 0.5 mg.
The required sample size was calculated using the G*Power software version 3.1.7 (Moorenstraße 5, 40225 Düsseldorf, Germany). The primary outcome measures were the differences between the two groups with regard to the hemodynamic measures and the BIS. The secondary outcome measures were the dose of ketofol, etomidate, and the end-tidal sevoflurane concentration. It was estimated that a sample of 25 patients in either study group would achieve a power of 80% to detect a statistically significant difference between the two groups for a large effect size of d = 0.8. This calculation used the unpaired t-test and assumed a two-sided type I error of 0.05. An effect size of d = 0.8 was chosen as it could be regarded as a clinically relevant difference to seek in this exploratory study.
Data were analyzed using IBM© SPSS© Statistics version 22 (IBM© Corp., Armonk, New York, USA) and MedCalc© version 13 (MedCalc© Software bvba, Ostend, Belgium). The D'Agostino-Pearson test was used to examine the normality of numerical data distribution. Normally distributed numerical variables were presented as mean and SD, and intergroup differences were compared using the independent samples (unpaired) t-test. The paired t-test was used for within-group comparison of paired measures.
Repeated-measures analysis of variance was used to analyze serial measurements. Repeated measures were compared with baseline values using the Bonferroni test.
Mixed-linear modeling was used to examine the effect of time, randomization group, and time-group interaction on the percent change in the outcome measures from baseline.
A two-sided P-value less than 0.05 was considered statistically significant.
| Results|| |
The flow of patients throughout the trial is shown in [Figure 2]. No significant differences between the two groups with respect to patient characteristics, hemoglobin level and intubation time [Table 1]. There were no significant differences between both groups regarding the time to loss of eyelash reflex (120.5 ± 10.8 s in group K versus 120.0 ± 10.3 s in group E, P = 0.862), and time to reach BIS of 60 (136.0 ± 12.1 s in group K vs. 135.3 ± 11.2 s in group E, P = 0.838) [Table 1]. In the postinduction and preintubation period, MAP, SVR, and BIS decreased significantly compared with baseline values in both groups, whereas CO and SV remained almost unchanged [Table 2] [Table 3] [Table 4] and [Figure 3], [Figure 4]. With intubation, MAP and SVR were significantly increased (P < 0.0001) in both groups and remained significantly high up to 4 min after intubation in comparison with baseline, whereas CO and SV remain almost unchanged. However, there was no significant difference between both groups with respect to CO, SV, MAP, SVR, HR, and BIS at each time interval [Table 2] [Table 3] [Table 4] and [Figure 3], [Figure 4]. Mixed-linear modeling for the percent variation from baseline in hemodynamic measures and BIS [Table 5] showed that except for the CO (P = 0.001), there was no significant difference between the two groups with regard to the trend in the percent change from baseline for the MAP (P = 0.590), HR (P = 0.079), SV (P = 0.824), SVR (P = 0.685), and BIS (P = 0.261). No anesthetic complications such as hypotension or bradycardia were recorded. There was no significant difference between both groups with respect to end-tidal CO 2 at 1 and 5 min postintubation [P = 0.930 and 0.377, respectively [Table 5]]. In addition, there was no significant difference between both groups with respect to end-tidal sevoflurane % at 1 and 5 min postintubation (P = 0.541 and 0.726) [Table 6]. The mean consumed anesthetic doses were 0.97 ± 0.1 mg/kg of either propofol or ketamine in group K and 0.14 ± 0.01 mg/kg for group E [Table 6].
|Figure 3: Change in hemodynamic variables and bispectral index (BIS) in both study groups. Error bars represent 95% confidence int erval (CI).|
Click here to view
|Figure 4: Percent change from baseline in hemodynamic variables and bispectral index (BIS) in both study groups. Error bars represent 95% confidence int erval (CI).|
Click here to view
|Table 1: Patients' characteristics and details of the induction of anesthesia and intubation in both groups|
Click here to view
|Table 4: Changes in systemic vascular resistance and bispectral index in both groups|
Click here to view
|Table 5: Mixed linear modeling for the percent variation from baseline in hemodynamic measures and bispectral index|
Click here to view
|Table 6: Change in end-tidal carbon dioxide and sevoflurane concentration in both groups|
Click here to view
| Discussion|| |
The use of propofol-ketamine mixture for the induction of anesthesia maintained the cardiovascular stability and reduced the required dose of both drugs to achieve adequate depth of anesthesia. Administration of ketamine and propofol mixed in the same syringe (so-called ketofol) has been proved to be effective in providing adequate sedation in day-care surgeries ,, .
The hemodynamic stability associated with etomidate makes it the drug of choice for induction in hypotensive patients, as well as an attractive option for patients with intracranial pathology for which hypotension should be avoided ,,,, . However, etomidate causes primary adrenal suppression owing to reversible inhibition of 11-β-hydroxylase enzyme essential for adrenal steroid production  . The cortisol suppression induced by a single dose of etomidate is almost temporary and limited to 24 h , .
The influence of BIS-guided infusion of etomidate and ketofol on hemodynamics before, during, and after tracheal intubation in patients undergoing elective surgery was studied. The time frame of the study (−6 to 16 min after intubation) was selected on the basis of already described pharmacokinetics and pharmacodynamics of the study drugs and timing related to surgical stimulation that might affect hemodynamics ,,, .
Noninvasive CO, SV, and SVR measurements are used nowadays on a big scale than invasive ones owing to lower risk of complications. CNAP monitor provides accurate beat-to-beat measurement of CO, MAP, SV, and SVR by analyzing the arterial blood pressure tracing without arterial cannulation ,, .
The aim of infusion technique of induction agents to BIS 60 in the present study was to decrease the total dose of induction agents with subsequent decrease in hemodynamic attenuation. The BIS monitor is validated for measuring the depth of anesthesia , . Ketofol has been used as bolus to provide sedation and analgesia for painful procedures in the emergency room  and as infusion to provide anesthesia for coronary artery surgery  . A study by Aouad et al.  reported that addition of ketamine to propofol for procedural anesthesia in children has reduced propofol and fentanyl consumption with maintenance of hemodynamics. The present study showed that ketofol infusion resulted in reduction of both propofol (0.97 ± 0.11 mg/kg) and ketamine (0.97 ± 0.11 mg/kg) doses required to achieve adequate depth of anesthesia, which comes in agreement with the results of studies conducted by Guit et al.  and Gray et al.  .
Several trials were conducted for comparison between induction of anesthesia by etomidate by bolus versus infusion method in which the latter method was superior to the former in decreasing consumption of anesthetics and achievement of better hemodynamic stability, which agrees with the results of the present study , . The infusion speed of anesthetics used in the present study was based on previous trials ,, .
In the current study on preintubation, there were no changes in SV and CO, whereas a decrease in MAP in both groups was noticed. This decrease in MAP may be attributed to attenuation of the vasomotor tone proved by a significant decrease in SVR that might be caused by the concomitant administration of fentanyl. Postintubation, MAP and SVR increased significantly in both groups and remained significantly high up to 4 min with respect to baseline, whereas CO and SV remain almost unchanged. The elevation of MAP and SVR during intubation might be because of the pressor response of intubation. However, it did not require interference in any patient as per the study protocol. Stability of CO and SV is observed in the present study, despite decrease in MAP before intubation and its increase during and after intubation that may be owing to the BIS-guided infusion of induction agents technique used, which allowed smaller total anesthetic dose. In the study, no hemodynamic complications occurred in any patient necessitating interference. Möller Petrun and Kamenik  compared BIS-guided induction of anesthesia by etomidate and propofol as they reported significant increase in MAP and cardiac index in the etomidate group and significant decrease in MAP in propofol group with 50% of patients developed hemodynamic instability. On the contrary, the current study revealed hemodynamic stability with adding ketamine to propofol as the former might attenuated the cardiovascular depressant effect of propofol. In addition, in their study, they included patients with ASA III classification, whereas in the present study only ASA I, II patients were selected. Similar to the present study, a study by Khutia et al.  also concluded that combination of ketamine and propofol is more safe and an effective sedative analgesic regimen than the combination of propofol and fentanyl in pediatric emergency and short surgical procedures in terms of hemodynamic stability and less incidence of apnea. Bendel et al.  performed BIS-guided anesthesia induction in patients with aortic stenosis using either propofol or etomidate infusion where propofol was found to induce hypotension as twice as did etomidate. Lallemand et al.  studied the effect of different bolus doses of etomidate (0.2, 0.3, and 0.4 mg/kg) on patients' hemodynamics with no significant differences. The present study did not include patients with ASA classification³III and older than 60 years for which further study is recommended to assess the cardiovascular response on such patients' status. The present study used fentanyl in a dose of 2 μg/kg that might have affected the measured cardiovascular parameters. Further studies need to be conducted using ketofol and etomidate, each as a single anesthetic agent without addition of fentanyl.
| Conclusion|| |
BIS-guided induction of anesthesia with either ketofol or etomidate infusion were effective in maintaining overall cardiovascular stability and reduced the total induction doses of both anesthetic agents. However, both techniques did not prevent some hemodynamic changes such as preintubation hypotension, despite titration of anesthetic agents to an appropriate anesthesia depth.
| Acknowledgements|| |
Conflicts of interest
| References|| |
Ebert TJ, Muzi M, Berens R, Goff D, Kampine JP. Sympathetic responses to induction of anesthesia in humans with propofol or etomidate. Anesthesiology 1992; 76:725-733.
Scheffer GJ, Ten Voorde BJ, Karemaker JM, Ros HH, de Lange JJ. Effects of thiopentone, etomidate and propofol on beat-to-beat cardiovascular signals in man. Anaesthesia 1993; 48:849-855.
Larsen R, Rathgeber J, Bagdahn A, Lange H, Rieke H. Effects of propofol on cardiovascular dynamics and coronary blood flow in geriatric patients. A comparison with etomidate. Anaesthesia 1988; 43:Suppl:25-31.
Harris CE, Murray AM, Anderson JM, Grounds RM, Morgan M. Effects of thiopentone, etomidate and propofol on the haemodynamic response to tracheal intubation. Anaesthesia 1988; 43:Suppl:32-36.
Heath PJ, Kennedy DJ, Ogg TW, Dunling C, Gilks WR. Which intravenous induction agent for day surgery? A comparison of propofol, thiopentone, methohexitone and etomidate. Anaesthesia 1988; 43:365-368.
Gillies GW, Lees NW. The effects of speed of injection on induction with propofol. A comparison with etomidate. Anaesthesia 1989;44:386-388.
Gauss A, Heinrich H, Wilder-Smith OH. Echocardiographic assessment of the haemodynamic effects of propofol: a comparison with etomidate and thiopentone. Anaesthesia 1991; 46:99-105.
McCollum JS, Dundee JW. Comparison of induction characteristics of four intravenous anaesthetic agents. Anaesthesia 1986; 41:995-1000.
Dhungana Y, Bhattarai BK, Bhadani UK, Biswas BK, Tripathi M. Prevention of hypotension during propofol induction: a comparison of preloading with 3.5% polymers of degraded gelatin (Haemaccel) and intravenous ephedrine. Nepal Med Coll J 2008; 10:16-19.
Yamaura K, Hoka S, Okamoto H, Kandabashi T, Akiyoshi K, Takahashi S. Changes in left ventricular end-diastolic area, end-systolic wall stress, and fractional area change during anesthetic induction with propofol or thiamylal. J Anesth 2000; 14:138-142.
Arora S. Combining ketamine and propofol ('ketofol') for emergency department procedural sedation and analgesia: a review. West J Emerg Med 2008; 9:20-23.
Guit JB, Koning HM, Coster ML, Niemeijer RP, Mackie DP. Ketamine as analgesic for total intravenous anaesthesia with propofol. Anaesthesia 1991; 46:24-27.
Gray C, Swinhoe CF, Myint Y, Mason D. Target controlled infusion of ketamine as analgesia for TIVA with propofol. Can J Anaesth 1999; 46:957-961.
Morse Z, Sano K, Kanri T. Effects of a propofol - ketamine admixture in human volunteers. Pac Health Dialog 2003; 10:51-54.
Liou CM, Hung WT, Chen CC, Hsu SC, Lau HK. Improving the success rate of laryngeal mask airway insertion during etomidate induction by using fentanyl or succinylcholine. Acta Anaesthesiol Taiwan 2004; 42:209-213.
Camu F, Vanlersberghe C. Pharmacology of systemic analgesics. Best Pract Res Clin Anaesthesiol 2002; 16:475-488.
Frey K, Sukhani R, Pawlowski J, Pappas AL, Mikat-Stevens M, Slogoff S. Propofol versus propofol-ketamine sedation for retrobulbar nerve block: comparison of sedation quality, intraocular pressure changes, and recovery profiles. Anesth Analg 1999; 89:317-321.
Mortero RF, Clark LD, Tolan MM, Metz RJ, Tsueda K, Sheppard RA The effects of small-dose ketamine on propofol sedation: respiration, postoperative mood, perception, cognition, and pain. Anesth Analg 2001; 92:1465-1469.
Benson M, Junger A, Fuchs C, Quinzio L, Böttger S, Hempelmann G. Use of an anesthesia information management system (AIMS) to evaluate the physiologic effects of hypnotic agents used to induce anesthesia. J Clin Monit Comput 2000; 16:183-190.
Fuchs-Buder T, Sparr HJ, Ziegenfuss T. Thiopental or etomidate for rapid sequence induction with rocuronium. Br J Anaesth 1998; 80:504-506.
Guldner G, Schultz J, Sexton P, Fortner C, Richmond M. Etomidate for rapid-sequence intubation in young children: hemodynamic effects and adverse events. Acad Emerg Med 2003; 10:134-139.
Sokolove PE, Price DD, Okada P. The safety of etomidate for emergency rapid sequence intubation of pediatric patients. Pediatr Emerg Care 2000; 16:18-21.
Oglesby AJ. Should etomidate be the induction agent of choice for rapid sequence intubation in the emergency department? Emerg Med J 2004; 21:655-659.
Wagner RL, White PF, Kan PB, Rosenthal MH, Feldman D. Inhibition of adrenal steroidogenesis by the anesthetic etomidate. N Engl J Med 1984; 310:1415-1421.
Zurick A, Sigurdsson H, Koehler L. Magnitude and time course of perioperative adrenal suppression with single dose etomidate in male adult cardiac surgical patients. Anesthesiology 1986; 65:248.
Anil K, Neeti M, Sandeep C, Sambhunath D, Usha K, Bisoi AK, Lakshmy R. The effects of etomidate and propofol induction on hemodynamic and endocrine response in patients undergoing coronary artery bypass graft surgery on cardiopulmonary bypass. World J Cardiovasc Surg 2012; 2:48-53.
Forman SA. Clinical and molecular pharmacology of etomidate. Anesthesiology 2011; 114:695-707.
White M, Schenkels MJ, Engbers FH, Vletter A, Burm AG, Bovill JG, Kenny GN. Effect-site modelling of propofol using auditory evoked potentials. Br J Anaesth 1999; 82:333-339.
Struys MM, Coppens MJ, De Neve N, Mortier EP, Doufas AG, Van Bocxlaer JF, Shafer SL. Influence of administration rate on propofol plasma-effect site equilibration. Anesthesiology 2007; 107:386-396.
Kaneda K, Yamashita S, Woo S, Han TH. Population pharmacokinetics and pharmacodynamics of brief etomidate infusion in healthy volunteers. J Clin Pharmacol 2011; 51:482-491.
Jeleazcov C, Krajinovic L, Münster T, Birkholz T, Fried R, Schüttler J, Fechner J. Precision and accuracy of a new device (CNAPTM) for continuous non-invasive arterial pressure monitoring: assessment during general anaesthesia. Br J Anaesth 2010; 105:264-272.
Biais M, Vidil L, Roullet S, Masson F, Quinart A, Revel P, Sztark F. Continuous non-invasive arterial pressure measurement: evaluation of CNAP device during vascular surgery. Ann Fr Anesth Reanim 2010; 29:530-535.
Jagadeesh AM, Singh NG, Mahankali S. A comparison of a continuous noninvasive arterial pressure (CNAPTM) monitor with an invasive arterial blood pressure monitor in the cardiac surgical ICU. Ann Cardiac Anaesth 2012; 15:180-184.
Johansen JW. Update on bispectral index monitoring. Best Pract Res Clin Anaesthesiol 2006; 20:81-99.
Mashour GA. Monitoring consciousness: EEG-based measures of anesthestic depth. Semin Anesth Perioperat Med Pain 2006; 25:205-210.
Willman EV, Andolfatto G. A prospective evaluation of 'ketofol' (ketamine/propofol combination) for procedural sedation and analgesia in the emergency department. Ann Emerg Med 2007; 49:23-30.
Carlos A, Charles E, Holbrook C, Altagracia M, Norman J, Joan F, Alfred C. Total intravenous anesthesia with a propofol-ketamine combination during coronary artery surgery. J Cardiothorac Vasc Anesth 2000; 14:409-415.
Aouad MT, Moussa AR, Dagher CM, Muwakkit SA, Jabbour-Khoury SI, Zbeidy RA, et al.
Addition of ketamine to propofol for initiation of procedural anesthesia in children reduces propofol consumption and preserves hemodynamic stability. Acta Anaesthesiol Scand 2008; 52:561-565.
Bergen JM, Smith DC. A review of etomidate for rapid sequence intubation in the emergency department. J Emerg Med 1997; 15:221-230.
Chan VW, Chung FF. Propofol infusion for induction and maintenance of anesthesia in elderly patients: recovery and hemodynamic profiles. J Clin Anesth 1996; 8:317-323.
Scorgie B. Etomidate infusion. Its use in anaesthesia for general surgery. Anaesthesia 1983; 38:Suppl:63-65.
Möller Petrun A, Kamenik M. Bispectral index-guided induction of general anaesthesia in patients undergoing major abdominal surgery using propofol or etomidate: a double-blind, randomized, clinical trial. Br J Anaesth 2013; 110:388-396.
Khutia SK, Mandal MC, Das S, Basu SR. Intravenous infusion of ketamine-propofol can be an alternative to intravenous infusion of fentanyl-propofol for deep sedation and analgesia in paediatric patients undergoing emergency short surgical procedures. Indian J Anaesth 2012; 56:145-150.
Bendel S, Ruokonen E, Pölönen P, Uusaro A. Propofol causes more hypotension than etomidate in patients with severe aortic stenosis: a double-blind, randomized study comparing propofol and etomidate. Acta Anaesthesiol Scand 2007; 51:284-289.
Lallemand MA, Lentschener C, Mazoit JX, Bonnichon P, Manceau I, Ozier Y. Bispectral index changes following etomidate induction of general anaesthesia and orotracheal intubation. Br J Anaesth 2003; 91:341-346.
[Figure 1], [Figure 2], [Figure 3], [Figure 4]
[Table 1], [Table 2], [Table 3], [Table 4], [Table 5], [Table 6]